|

64Cu-LLP2A Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Early 1: 1

Top Sponsors

  • Washington University School of Medicine1

Indications

  • Low-Grade Lymphoma1
  • Lymphoplasmacytic Lymphoma1
  • Small Lymphocytic Lymphoma1
  • Chronic Lymphocytic Leukemia1
  • Marginal Zone Lymphoma1

St Louis, Missouri1 trial

64Cu-LLP2A for Imaging Hematologic Malignancies

Washington University School of Medicine

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.